Wednesday, October 12, 2016 1:59:36 PM
Pfizer already had big sales numbers for Celebrex. They know what the drug did to their bottom line. They have all the doctors on board with the drug, but only recently losing handful of cash due to generics. So not a lot of time or work to pop in revenue hard in 6 months. This could generate $3b+ a year after the second year for them. All the channels are in place.
Knowing how much they can make in a short time, wouldn't $1.5-4b buyout be on the table? Dexcel can't afford that, or maybe they can. I'm pretty sure Pfizer has been watching this for a while. All I'm saying is I see buyout talk on thesis of estimating sales being unknown, and usually buyouts are 2-4x annual revenue. So everyone is shooting low at $300-500m.
Run with this thesis though....this a superior drug to a known money maker of $3.3b worldwide right before generic. The sales channels are still in place so there really is no ramping up. The Celebrex and generic are making over $3b a year. It's a matter of communicating to doctors that they need to switch from generic or Celebrex to the improved version. Stop running sales figures as a brand new drug with no history of acceptance. Use current sales figures....past and future forecast...to obtain a fair buyout price.
My biggest fear is that they will just sell the drug and not the company. Leaving us with a ton of cash, but no future unless they find another drug to combo to package and sell.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM